CCND1 and Familial prostate cancer: It has also been associated with several anti-cancer mechanisms of action in prostate cancer including inhibition of complex 1[24], lipogenesis [25], decreases of cyclin D1[26], down-regulation of the insulin-like growth factor 1 receptor [27] and AR downregulation[28].